Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1α) and HIF-2α in stem cells

被引:221
作者
Hu, CJ
Iyer, S
Sataur, A
Covello, KL
Chodosh, LA
Simon, MC
机构
[1] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/MCB.26.9.3514-3526.2006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcriptional responses to hypoxia are primarily mediated by hypoxia-inducible factors (HIFs), HIF-1 alpha and HIF-2 alpha. The HIF-1 alpha and HIF-2 alpha subunits are structurally similar in their DNA binding and dimerization domains but differ in their transactivation domains, implying they may have unique target genes and require distinct transcriptional cofactors. Our previous results demonstrated that HIF-1 alpha and HIF-2 alpha regulate distinct target genes. Here, we report that HIF-2 alpha is not transcriptionally active in embryonic stem (ES) cells, as well as possible inhibition by a HIF-2 alpha-specific transcriptional repressor. Using DNA microarray analysis of hypoxia-inducible genes in wild-type (WT), Hif-1 alpha(-/-), and Hif-2 alpha(-/-) ES cells, we show that HIF-1 alpha induces a large number of both confirmed and novel hypoxia-inducible genes, while HIF-2a does not activate any of its previously described targets. We further demonstrate that inhibition of HIF-2a function occurs at the level of transcription cofactor recruitment to endogenous target gene promoters. Overexpression of WT and, notably, a DNA-binding-defective HIF-2 alpha mutant restores endogenous HIF-2a protein activity, suggesting that ES cells express a HIF-2 alpha-specific corepressor that can be titrated by overexpressed HIF-2 alpha protein. HIF-2 alpha repression may explain why patients with mutations in the VHL tumor suppressor gene display cancerous lesions in specific tissue types.
引用
收藏
页码:3514 / 3526
页数:13
相关论文
共 53 条
  • [31] The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma
    Maranchie, JK
    Vasselli, JR
    Riss, J
    Bonifacino, JS
    Linehan, WM
    Klausner, RD
    [J]. CANCER CELL, 2002, 1 (03) : 247 - 255
  • [32] The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
    Maxwell, PH
    Wiesener, MS
    Chang, GW
    Clifford, SC
    Vaux, EC
    Cockman, ME
    Wykoff, CC
    Pugh, CW
    Maher, ER
    Ratcliffe, PJ
    [J]. NATURE, 1999, 399 (6733) : 271 - 275
  • [33] Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4
    Nichols, J
    Zevnik, B
    Anastassiadis, K
    Niwa, H
    Klewe-Nebenius, D
    Chambers, I
    Schöler, H
    Smith, A
    [J]. CELL, 1998, 95 (03) : 379 - 391
  • [34] Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells
    Niwa, H
    Miyazaki, J
    Smith, AG
    [J]. NATURE GENETICS, 2000, 24 (04) : 372 - 376
  • [35] Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1α (HIF-1α):: Role of cytoplasmic trapping of HIF-2α
    Park, SK
    Dadak, AM
    Haase, VH
    Fontana, L
    Giaccia, AJ
    Johnson, RS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (14) : 4959 - 4971
  • [36] The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling
    Peng, J
    Zhang, LY
    Drysdale, L
    Fong, GH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) : 8386 - 8391
  • [37] In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations
    Rathmell, WK
    Hickey, MM
    Bezman, NA
    Chmielecki, CA
    Carraway, NC
    Simon, MC
    [J]. CANCER RESEARCH, 2004, 64 (23) : 8595 - 8603
  • [38] Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
    Raval, RR
    Lau, KW
    Tran, MGB
    Sowter, HM
    Mandriota, SJ
    Li, JL
    Pugh, CW
    Maxwell, PH
    Harris, AL
    Ratcliffe, PJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (13) : 5675 - 5686
  • [39] HIF-1α is required for solid tumor formation and embryonic vascularization
    Ryan, HE
    Lo, J
    Johnson, RS
    [J]. EMBO JOURNAL, 1998, 17 (11) : 3005 - 3015
  • [40] Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP
    Sang, NL
    Fang, J
    Srinivas, V
    Leshchinsky, I
    Caro, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (09) : 2984 - 2992